Tianjin Med J ›› 2018, Vol. 46 ›› Issue (8): 785-788.doi: 10.11958/20180747

    Next Articles

Precision diagnosis and therapy of myelodysplastic syndrome based on disease nature and our facility

SHAO Zong-hong, WANG Hua-quan   

  1. Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China
  • Received:2018-05-09 Revised:2018-06-21 Published:2018-08-15 Online:2018-08-23

Abstract: Abstract: The essence of myelodysplastic syndrome (MDS) is a malignant clonal bone marrow myeloid neoplasm. Both basic researches and clinical studies should firmly grasp this essence of MDS and should not be interferenced by confounding factors. Comprehensive diagnosis can improve the accuracy of MDS diagnosis by multiple indicators that reflect the malignant nature, such as cell dysplasia, function abnormalities, cytogenetic changes and gene mutations. The therapy of MDS should also eradicate the MDS clone, change the disease progression, stimulating normal hematopoiesis, prolong the survival and improve the quality of life.

Key words:  myelodysplastic syndromes, diagnosis, therapy, pathogenesis